| PARP1 |
P09874
|
poly(ADP-ribose) polymerase 1
|
|
3.3E-04 |
0.389 |
0.923 |
| ANXA5 |
P08758
|
annexin A5
|
|
3.8E-15 |
0.458 |
0.769 |
| APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
| APRT |
P07741
|
adenine phosphoribosyltransferase
|
|
5.5E-13 |
0.423 |
0.846 |
| BCL3 |
P20749
|
BCL3 transcription coactivator
|
|
0.99 |
0.541 |
0.731 |
| CEACAM1 |
P13688
|
CEA cell adhesion molecule 1
|
|
7.9E-04 |
0.525 |
0.731 |
| PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
| BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
| BSG |
P35613
|
basigin (Ok blood group)
|
|
2.6E-05 |
0.458 |
0.769 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| CDH1 |
P12830
|
cadherin 1
|
|
0.15 |
0.401 |
0.808 |
| CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
| CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CDKN2C |
P42773
|
cyclin dependent kinase inhibitor 2C
|
|
0.40 |
0.527 |
0.654 |
| CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
| CRK |
P46108
|
CRK proto-oncogene, adaptor protein
|
|
0.96 |
0.394 |
0.923 |
| CTNNB1 |
P35222
|
catenin beta 1
|
|
1.00 |
0.303 |
0.885 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| CYP2E1 |
P05181
|
cytochrome P450 family 2 subfamily E member 1
|
|
8.1E-09 |
0.459 |
0.885 |
| DDX3X |
O00571
|
DEAD-box helicase 3 X-linked
|
|
1.00 |
0.537 |
0.769 |
| DIO3 |
P55073
|
iodothyronine deiodinase 3
|
|
0.62 |
0.593 |
0.731 |
| DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
| EGF |
P01133
|
epidermal growth factor
|
|
8.5E-17 |
0.357 |
0.923 |